List view / Grid view
14 April 2016 | By SMi Group
SMi’s 16th annual Pain Therapeutics conference returns to London this May and is thrilled to have Dr Geert Jan Groeneveld, Research Director from the Centre for Human Drug Research, as one of the featured speakers for 2016...
14 April 2016 | By Victoria White, Digital Content Producer
Cancer cells use a mutant gene to coerce neighbouring healthy tissue into helping with the disease’s growth and spread, a major new study reports...
13 April 2016 | By Victoria White, Digital Content Producer
Mathematicians and physicians at the University of Bonn have developed a new model for cancer immunotherapy using mathematics...
13 April 2016 | By Victoria White, Digital Content Producer
The effects of LSD on the human brain have been visualised for the first time and may lead to new treatments for psychiatric disorders...
12 April 2016 | By Victoria White, Digital Content Producer
The discovery means that a family history of DCIS could be as important to assessing a woman’s risk as a history of invasive breast cancer...
12 April 2016 | By Caroline Richards, Editor, Drug Target Review
Here, Caroline Richards, Editor of Drug Target Review, discusses the publication and the opportunities available to authors...
8 April 2016 | By Victoria White, Digital Content Producer
A new study is the first to show that tumours can become resistant to drugs over time by learning to steal normal blood vessels from surrounding tissue...
8 April 2016 | By Victoria White
Nanoparticles designed to block a cell-surface molecule that plays a key role in inflammation could be a safe treatment for inflammatory bowel disease...
31 March 2016 | By Victoria White
Children with cancer will be offered testing for genetic mutations in their tumours as part of an initiative to personalise children’s cancer treatment...
Affimer® proteins are unique affinity proteins that exhibit high affinity and high specificity binding across a range of reaction conditions...
23 March 2016 | By Dr John Maher, Principal Investigator, National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) at Guy’s and St Thomas’ and Kings College London
Here, Dr John Maher of the NIHR BRC at Guy's and St Thomas' and Kings College London discusses CAR T-cell therapy and the exciting frontier the technique has opened up in the battle against cancer...
22 March 2016 | By Victoria White
Scientists have provided the first direct evidence of how proteins of the ABC-F family 'protect' the bacterial ribosome from being blocked by antibiotics...
22 March 2016 | By Victoria White
The Human Vaccines Project is focused on cross-sector collaboration to identify human immune responses associated with optimal vaccine protection...
21 March 2016 | By Victoria White
The discovery, a crucial step in bacteria's energy metabolism, may be the first step in developing an entirely novel form of antibiotics...
Long term success for pharmaceutical businesses depends upon harnessing the best tools available to bring safe and effective medicines to market at a competitive price, and to be truly successful, for such drugs to be first in class.
